ADMdx Overview
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.96M
- Investors
-
3
ADMdx General Information
Description
Developer of advanced neuroimaging analytics designed to enhance the detection and evaluation of neurological diseases. The company offers AI-driven imaging analysis, reporting tools, and biomarker-based clinical trial support services, enabling clinicians and research organizations to improve diagnostic accuracy and accelerate therapeutic development.
Contact Information
Website
www.admdx.comCorporate Office
- 555 Skokie Boulevard
- Suite 500
- Northbrook, IL 60062
- United States
Corporate Office
- 555 Skokie Boulevard
- Suite 500
- Northbrook, IL 60062
- United States
ADMdx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 27-Sep-2022 | $1.96M | Completed | Generating Revenue | ||
| 6. Angel (individual) | 30-May-2018 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 10-Jun-2016 | Completed | Generating Revenue | |||
| 4. Grant | 15-Apr-2013 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2012 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | 31-Jul-2010 | $200K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Aug-2009 | $200K | $200K | Completed | Generating Revenue |
ADMdx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
ADMdx Patents
ADMdx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10751019-B2 | Determining a brain condition using early time frame pet image analysis | Active | 16-Sep-2015 | ||
| US-20180256127-A1 | Determining a brain condition using early time frame pet image analysis | Active | 16-Sep-2015 | ||
| US-11272897-B2 | Systems and methods for determining a brain condition of a subject using early time frame pet image analysis | Active | 16-Sep-2015 | ||
| US-20210007697-A1 | Systems and methods for determining a brain condition of a subject using early time frame pet image analysis | Active | 16-Sep-2015 | ||
| US-11373311-B2 | System and methods for determining a brain condition of a patient subject to multiple disease states | Active | 15-Jul-2015 | G06T7/0012 |
ADMdx Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute on Aging | Government | |||
| University Technology Park | Accelerator/Incubator | |||
| US National Science Foundation | Accelerator/Incubator |
ADMdx FAQs
-
Where is ADMdx headquartered?
ADMdx is headquartered in Northbrook, IL.
-
What industry is ADMdx in?
ADMdx’s primary industry is Decision/Risk Analysis.
-
Is ADMdx a private or public company?
ADMdx is a Private company.
-
What is ADMdx’s current revenue?
The current revenue for ADMdx is .
-
How much funding has ADMdx raised over time?
ADMdx has raised $820K.
-
Who are ADMdx’s investors?
National Institute on Aging, University Technology Park, and US National Science Foundation have invested in ADMdx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process